Important Dates:
| Abstract Submission Open | June 7, 2022 |
| Abstract Submission Deadline | August 15, 2022 |
| Notification of Abstract Acceptance | TBA |
| Registration Deadline for Presenting Author | November 15, 2022 |
Abstract Submission Process
General Policy
All abstracts must be submitted and be received on or before August 15, 2022 through Online Abstract Submission System.
The user who submitted the abstract to the submission system would be recognized as the Presenting Author. The presenting author of an accepted abstract (oral and poster) must register and pay the registration fees no later than October 15, 2022 to ensure the rights for the presentation.
Abstracts must be original and have not been published or presented at any conference prior to the APASL 2023. The accepted abstracts will be published in the Abstract Book.
Presenting Authors of accepted abstracts MUST be registered delegates even if they are a student and be responsible for all expenses incurred in the production of their presentations, travel and accommodation during the Conference. Each Presenting Author can submit UNLIMITED abstracts and can also be a co-author of another abstract.
It is the author’s responsibility to submit a correctly edited and accurate abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author. Abstracts will be rejected if they contain no data or if the English is unacceptable. All Presenting Authors will receive detailed presentation guidelines when the abstract has been accepted.
Acknowledgement of the receipt of abstract submission will be sent to the Presenting Author’s email address immediately upon submission. The Presenting Author will receive all correspondence regarding the abstract status, presentation type, date and time, via the email that is provided in the abstract submission.
Abstract Category (Oral/ Poster)
| A. Basic Research | M. Fibrosis and Cirrhosis |
| B. Hepatitis B - Basic | N. Portal Hypertension and its complications |
| C. Hepatitis B - Clinical | O. Acute Liver Failure and ACLF |
| D. Hepatitis C - Basic | P. Liver Cancer - Basic |
| E. Hepatitis C - Clinical | Q. Liver Cancer - Clinical |
| F. Other Infection in Liver Disease | R. Other Hepatobiliary Neoplasia |
| G. Nonalcoholic Fatty Liver Disease - Basic | S. Liver Transplantation |
| H. Nonalcoholic Fatty Liver Disease - Clinical | T. Hepatobiliary Surgery |
| I. Alcoholic Liver Disease | U. Biliary and Pancreatic Disease |
| J. Autoimmune and Cholestatic Disease | V. Pediatric Hepatology |
| K. Drug-Induced Liver Injury | W. Other |
| L. Metabolic and Genetic Disease |
Submission Guidelines
The title of the Abstract:
The Body of the Abstract:
Note:
An abstract can only include up to 10 authors, moreover, should the co-authors be not filling in the submission system, and the co-authors will not be shown on the abstract book.
Authors are advised to ensure the accuracy of the submitted abstracts. Any mistakes in literature or scientific facts will be published as what is typed.
All authors named in the abstract have agreed to its submission for presentation and publish at the 32nd Conference of the Asian Pacific Association for the Study of the Liver (APASL 2023), and that the authors are familiar with and agree with the stated results.
This abstract conforms to all the 32nd Conference of the Asian Pacific Association for the Study of the Liver (APASL 2023) Abstract Rules and Procedures.
The Scientific Program Committee of the APASL 2023 reserves the right to accept or refuse an abstract, to designate abstracts either oral or poster presentation and to choose a suitable session for the abstract.
Award Application
Young Investigator Award
Applicant must be aged 45 years or younger at the time of application.
Applicant must be the first author of his/her abstract and a registered participant of the conference.
The shortlisted oral abstract must be presented by the applicant during the meeting.
Applicant must submit the training certification and curriculum vitae during online abstract submission.
For any inquiries regarding APASL 2023 abstract submissions, please contact:
Email: apasl2023.paper@elitepco.com.tw
